Annual Net Income
-$51.92 M
+$42.30 M+44.89%
31 December 2023
Summary:
Akebia Therapeutics annual net profit is currently -$51.92 million, with the most recent change of +$42.30 million (+44.89%) on 31 December 2023. During the last 3 years, it has risen by +$332.92 million (+86.51%). AKBA annual net income is now -533.54% below its all-time high of -$8.20 million, reached on 31 December 2012.AKBA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$20.04 M
-$11.46 M-133.50%
30 September 2024
Summary:
Akebia Therapeutics quarterly net profit is currently -$20.04 million, with the most recent change of -$11.46 million (-133.50%) on 30 September 2024. Over the past year, it has dropped by -$5.55 million (-38.30%). AKBA quarterly net income is now -168.05% below its all-time high of $29.45 million, reached on 30 June 2022.AKBA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$45.99 M
-$5.55 M-13.72%
30 September 2024
Summary:
Akebia Therapeutics TTM net profit is currently -$45.99 million, with the most recent change of -$5.55 million (-13.72%) on 30 September 2024. Over the past year, it has increased by +$12.62 million (+21.53%). AKBA TTM net income is now -7307.31% below its all-time high of -$620.90 thousand, reached on 31 March 2013.AKBA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.9% | -38.3% | +21.5% |
| 3 y3 years | +86.5% | +66.3% | +84.7% |
| 5 y5 years | +63.8% | +63.3% | +81.3% |
AKBA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +86.5% | -168.1% | +71.3% | -13.7% | +84.7% |
| 5 y | 5 years | at high | +86.5% | -168.1% | +88.6% | -13.7% | +88.3% |
| alltime | all time | -533.5% | +86.5% | -168.1% | +88.6% | -7307.3% | +88.3% |
Akebia Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.04 M(+133.5%) | -$45.99 M(+13.7%) |
| June 2024 | - | -$8.58 M(-52.3%) | -$40.44 M(-6.0%) |
| Mar 2024 | - | -$17.98 M(-3029.2%) | -$43.03 M(-17.1%) |
| Dec 2023 | -$51.92 M(-44.9%) | $614.00 K(-104.2%) | -$51.92 M(-11.4%) |
| Sept 2023 | - | -$14.49 M(+29.7%) | -$58.61 M(-40.3%) |
| June 2023 | - | -$11.17 M(-58.4%) | -$98.22 M(+70.5%) |
| Mar 2023 | - | -$26.88 M(+342.7%) | -$57.59 M(-38.2%) |
| Dec 2022 | -$94.23 M(-66.6%) | -$6.07 M(-88.8%) | -$93.14 M(-40.6%) |
| Sept 2022 | - | -$54.10 M(-283.7%) | -$156.93 M(-3.4%) |
| June 2022 | - | $29.45 M(-147.2%) | -$162.38 M(-40.9%) |
| Mar 2022 | - | -$62.42 M(-10.7%) | -$274.87 M(-2.5%) |
| Dec 2021 | -$282.02 M(-26.7%) | -$69.86 M(+17.3%) | -$282.02 M(-6.2%) |
| Sept 2021 | - | -$59.54 M(-28.3%) | -$300.55 M(-0.1%) |
| June 2021 | - | -$83.04 M(+19.3%) | -$300.96 M(-23.6%) |
| Mar 2021 | - | -$69.58 M(-21.3%) | -$393.67 M(+2.3%) |
| Dec 2020 | -$384.84 M(+37.6%) | -$88.38 M(+47.4%) | -$384.84 M(-1.6%) |
| Sept 2020 | - | -$59.96 M(-65.9%) | -$390.94 M(+1.4%) |
| June 2020 | - | -$175.75 M(+189.3%) | -$385.57 M(+43.9%) |
| Mar 2020 | - | -$60.75 M(-35.7%) | -$267.99 M(-4.2%) |
| Dec 2019 | -$279.66 M(+94.8%) | -$94.48 M(+73.1%) | -$279.66 M(+14.0%) |
| Sept 2019 | - | -$54.59 M(-6.2%) | -$245.23 M(+13.2%) |
| June 2019 | - | -$58.17 M(-19.7%) | -$216.69 M(+12.5%) |
| Mar 2019 | - | -$72.42 M(+20.6%) | -$192.59 M(+34.1%) |
| Dec 2018 | -$143.59 M | -$60.05 M(+130.6%) | -$143.59 M(+111.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$26.05 M(-23.5%) | -$68.01 M(+4.5%) |
| June 2018 | - | -$34.07 M(+45.5%) | -$65.10 M(+23.9%) |
| Mar 2018 | - | -$23.42 M(-250.9%) | -$52.55 M(-28.7%) |
| Dec 2017 | -$73.67 M(-45.7%) | $15.52 M(-167.1%) | -$73.67 M(-42.0%) |
| Sept 2017 | - | -$23.13 M(+7.5%) | -$127.06 M(-9.4%) |
| June 2017 | - | -$21.52 M(-51.7%) | -$140.23 M(-9.2%) |
| Mar 2017 | - | -$44.54 M(+17.6%) | -$154.49 M(+13.8%) |
| Dec 2016 | -$135.75 M(+123.6%) | -$37.86 M(+4.3%) | -$135.75 M(+15.3%) |
| Sept 2016 | - | -$36.31 M(+1.5%) | -$117.74 M(+16.7%) |
| June 2016 | - | -$35.78 M(+38.7%) | -$100.91 M(+33.1%) |
| Mar 2016 | - | -$25.80 M(+29.9%) | -$75.82 M(+24.9%) |
| Dec 2015 | -$60.72 M(+63.9%) | -$19.86 M(+2.0%) | -$60.72 M(+18.5%) |
| Sept 2015 | - | -$19.48 M(+82.2%) | -$51.23 M(+24.6%) |
| June 2015 | - | -$10.69 M(-0.1%) | -$41.10 M(+8.1%) |
| Mar 2015 | - | -$10.70 M(+3.1%) | -$38.03 M(+2.7%) |
| Dec 2014 | -$37.03 M(+181.3%) | -$10.37 M(+10.9%) | -$37.03 M(+13.6%) |
| Sept 2014 | - | -$9.35 M(+22.7%) | -$32.61 M(+20.6%) |
| June 2014 | - | -$7.62 M(-21.4%) | -$27.03 M(+21.5%) |
| Mar 2014 | - | -$9.70 M(+63.0%) | -$22.24 M(+68.9%) |
| Dec 2013 | -$13.17 M(+60.7%) | -$5.95 M(+57.9%) | -$13.17 M(+82.4%) |
| Sept 2013 | - | -$3.77 M(+33.1%) | -$7.22 M(+109.2%) |
| June 2013 | - | -$2.83 M(+355.9%) | -$3.45 M(+455.9%) |
| Mar 2013 | - | -$620.90 K | -$620.90 K |
| Dec 2012 | -$8.20 M | - | - |
FAQ
- What is Akebia Therapeutics annual net profit?
- What is the all time high annual net income for Akebia Therapeutics?
- What is Akebia Therapeutics annual net income year-on-year change?
- What is Akebia Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly net income year-on-year change?
- What is Akebia Therapeutics TTM net profit?
- What is the all time high TTM net income for Akebia Therapeutics?
- What is Akebia Therapeutics TTM net income year-on-year change?
What is Akebia Therapeutics annual net profit?
The current annual net income of AKBA is -$51.92 M
What is the all time high annual net income for Akebia Therapeutics?
Akebia Therapeutics all-time high annual net profit is -$8.20 M
What is Akebia Therapeutics annual net income year-on-year change?
Over the past year, AKBA annual net profit has changed by +$42.30 M (+44.89%)
What is Akebia Therapeutics quarterly net profit?
The current quarterly net income of AKBA is -$20.04 M
What is the all time high quarterly net income for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly net profit is $29.45 M
What is Akebia Therapeutics quarterly net income year-on-year change?
Over the past year, AKBA quarterly net profit has changed by -$5.55 M (-38.30%)
What is Akebia Therapeutics TTM net profit?
The current TTM net income of AKBA is -$45.99 M
What is the all time high TTM net income for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM net profit is -$620.90 K
What is Akebia Therapeutics TTM net income year-on-year change?
Over the past year, AKBA TTM net profit has changed by +$12.62 M (+21.53%)